在格拉斯哥举行的HIV药物治疗会议上，一份病例报告显示， 一名接受具有罕见突变（该突变可阻止病毒进入细胞）的供体干细胞移植以治疗癌症的患者，可能成为 第八例长期病毒缓解的HIV感染者。

第一个成功的治愈案例是蒂莫西·雷·布朗，被称为“柏林患者”。2006年，他因急性髓性白血病接受了两次干细胞移植。柏林查理特医院的肿瘤学专家Gero Hütter博士提出使用带有CCR5-delta32突变的供体干细胞，这种突变可以阻止大多数HIV病毒进入细胞。

The decrease in CD4 cells during HIV infection seems to be driven by immune ... and higher LPS levels were associated with greater activation of CD8 + lymphocytes. CD8 + activation also was ...

In recent years, greater emphasis has been placed on the CD4/CD8 dynamic in the aging HIV population. In its simplest form, we know that CD4 counts of less than 200 places a person with HIV at ...

This emerging picture also suggests that if a vaccine does not create a sterilizing barrier, it will likely need to induce strong, HIV-specific CD4 helper cell activity that can be present at the ...